National Research (NASDAQ:NRC) Sets New 52-Week Low at $21.63

National Research Co. (NASDAQ:NRC)’s share price reached a new 52-week low on Wednesday . The stock traded as low as $21.63 and last traded at $21.63, with a volume of 9694 shares traded. The stock had previously closed at $22.79.

National Research Trading Down 8.2 %

The firm’s 50-day simple moving average is $24.70 and its 200-day simple moving average is $32.53. The firm has a market capitalization of $499.51 million, a PE ratio of 17.05 and a beta of 0.49. The company has a quick ratio of 0.41, a current ratio of 0.41 and a debt-to-equity ratio of 0.75.

National Research (NASDAQ:NRC) last issued its earnings results on Tuesday, May 7th. The company reported $0.27 earnings per share for the quarter. The company had revenue of $35.31 million during the quarter. National Research had a return on equity of 54.83% and a net margin of 20.60%.

Institutional Investors Weigh In On National Research

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. CWM LLC grew its position in shares of National Research by 889.7% in the 2nd quarter. CWM LLC now owns 1,158 shares of the company’s stock worth $27,000 after buying an additional 1,041 shares during the last quarter. Benjamin F. Edwards & Company Inc. lifted its position in shares of National Research by 860.2% in the 1st quarter. Benjamin F. Edwards & Company Inc. now owns 1,133 shares of the company’s stock worth $45,000 after purchasing an additional 1,015 shares during the period. Gladius Capital Management LP boosted its stake in shares of National Research by 59.8% during the 4th quarter. Gladius Capital Management LP now owns 1,326 shares of the company’s stock valued at $52,000 after purchasing an additional 496 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank boosted its stake in shares of National Research by 184.3% during the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 3,179 shares of the company’s stock valued at $126,000 after purchasing an additional 2,061 shares in the last quarter. Finally, SG Americas Securities LLC purchased a new position in shares of National Research during the fourth quarter valued at about $147,000. 47.26% of the stock is currently owned by institutional investors.

About National Research

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty.